NeuroOne Medical Technologies (NMTC) shares rose more than 9% in recent trading Friday after it said it expects fiscal Q1 revenue of $6.2 million, up from $1 million a year earlier.
The company said the quarter ended Dec. 31, 2024, includes a one-time $3 million payment of collaboration revenue from the expanded distribution deal with Zimmer Biomet Holdings (ZBH) for commercialization of NeuroOne's OneRF Ablation System.
Price: 1.17, Change: +0.10, Percent Change: +9.35
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。